Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 30;4(4):e0672.
doi: 10.1097/CCE.0000000000000672. eCollection 2022 Apr.

Methods for Phenotyping Adult Patients in Sepsis and Septic Shock: A Scoping Review

Affiliations

Methods for Phenotyping Adult Patients in Sepsis and Septic Shock: A Scoping Review

Han Li et al. Crit Care Explor. .

Abstract

Despite its heterogeneous phenotypes, sepsis or life-threatening dysfunction in response to infection is often treated empirically. Identifying patient subgroups with unique pathophysiology and treatment response is critical to the advancement of sepsis care. However, phenotyping methods and results are as heterogeneous as the disease itself. This scoping review evaluates the prognostic capabilities and treatment implications of adult sepsis and septic shock phenotyping methods.

Data sources: Medline and Embase.

Study selection: We included clinical studies that described sepsis or septic shock and used any clustering method to identify sepsis phenotypes. We excluded conference abstracts, literature reviews, comments, letters to the editor, and in vitro studies. We assessed study quality using a validated risk of bias tool for observational cohort and cross-sectional studies.

Data extraction: We extracted population, methodology, validation, and phenotyping characteristics from 17 studies.

Data synthesis: Sepsis phenotyping methods most frequently grouped patients based on the degree of inflammatory response and coagulopathy using clinical, nongenomic variables. Five articles clustered patients based on genomic or transcriptomic data. Seven articles generated patient subgroups with differential response to sepsis treatments. Cluster clinical characteristics and their associations with mortality and treatment response were heterogeneous across studies, and validity was evaluated in nine of 17 articles, hindering pooled analysis of results and derivation of universal truths regarding sepsis phenotypes, their prognostic capabilities, and their associations with treatment response.

Conclusions: Sepsis phenotyping methods can identify high-risk patients and those with high probability of responding well to targeted treatments. Research quality was fair, but achieving generalizability and clinical impact of sepsis phenotyping will require external validation and direct comparison with alternative approaches.

Keywords: cluster analyses; infections; machine learning; risk assessment; sepsis; septic shock.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Preferred Reporting Items for Systematic Review diagram of study selection.
Figure 2.
Figure 2.
Study risk of bias assessments and reasoning. APACHE = Acute Physiology And Chronic Health Evaluation, EMR = Electronic Medical Record, SOFA = Sequential Organ Failure Assessment.

References

    1. Prescott HC, Angus DC: Enhancing recovery from sepsis: A review. JAMA 2018; 319:62–75 - PMC - PubMed
    1. Rhee C, Jones TM, Hamad Y, et al. ; Centers for Disease Control and Prevention (CDC) Prevention Epicenters Program: Prevalence, underlying causes, and preventability of sepsis-associated mortality in US acute care hospitals. JAMA Netw Open 2019; 2:e187571. - PMC - PubMed
    1. Singer M, Deutschman CS, Seymour CW, et al. : The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 2016; 315:801–810 - PMC - PubMed
    1. van der Poll T, van de Veerdonk FL, Scicluna BP, et al. : The immunopathology of sepsis and potential therapeutic targets. Nat Rev Immunol 2017; 17:407–420 - PubMed
    1. Meisel C, Schefold JC, Pschowski R, et al. : Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: A double-blind, randomized, placebo-controlled multicenter trial. Am J Respir Crit Care Med 2009; 180:640–648 - PubMed

Publication types